Design and Rationale for the Use of Magnetic Resonance Imaging Biomarkers to Predict Diabetes After Acute Pancreatitis in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium. Issue 6 (July 2022)
- Record Type:
- Journal Article
- Title:
- Design and Rationale for the Use of Magnetic Resonance Imaging Biomarkers to Predict Diabetes After Acute Pancreatitis in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium. Issue 6 (July 2022)
- Main Title:
- Design and Rationale for the Use of Magnetic Resonance Imaging Biomarkers to Predict Diabetes After Acute Pancreatitis in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study
- Authors:
- Tirkes, Temel
Chinchilli, Vernon M.
Bagci, Ulas
Parker, Jason G.
Zhao, Xuandong
Dasyam, Anil K.
Feranec, Nicholas
Grajo, Joseph R.
Shah, Zarine K.
Poullos, Peter D.
Spilseth, Benjamin
Zaheer, Atif
Xie, Karen L.
Wachsman, Ashley M.
Campbell-Thompson, Martha
Conwell, Darwin L.
Fogel, Evan L.
Forsmark, Christopher E.
Hart, Phil A.
Pandol, Stephen J.
Park, Walter G.
Pratley, Richard E.
Yazici, Cemal
Laughlin, Maren R.
Andersen, Dana K.
Serrano, Jose
Bellin, Melena D.
Yadav, Dhiraj - Abstract:
- Abstract: This core component of the Diabetes RElated to Acute pancreatitis and its Mechanisms (DREAM) study will examine the hypothesis that advanced magnetic resonance imaging (MRI) techniques can reflect underlying pathophysiologic changes and provide imaging biomarkers that predict diabetes mellitus (DM) after acute pancreatitis (AP). A subset of participants in the DREAM study will enroll and undergo serial MRI examinations using a specific research protocol. The aim of the study is to differentiate at-risk individuals from those who remain euglycemic by identifying parenchymal features after AP. Performing longitudinal MRI will enable us to observe and understand the natural history of post-AP DM. We will compare MRI parameters obtained by interrogating tissue properties in euglycemic, prediabetic, and incident diabetes subjects and correlate them with metabolic, genetic, and immunological phenotypes. Differentiating imaging parameters will be combined to develop a quantitative composite risk score. This composite risk score will potentially have the ability to monitor the risk of DM in clinical practice or trials. We will use artificial intelligence, specifically deep learning, algorithms to optimize the predictive ability of MRI. In addition to the research MRI, the DREAM study will also correlate clinical computed tomography and MRI scans with DM development.
- Is Part Of:
- Pancreas. Volume 51:Issue 6(2022)
- Journal:
- Pancreas
- Issue:
- Volume 51:Issue 6(2022)
- Issue Display:
- Volume 51, Issue 6 (2022)
- Year:
- 2022
- Volume:
- 51
- Issue:
- 6
- Issue Sort Value:
- 2022-0051-0006-0000
- Page Start:
- 586
- Page End:
- 592
- Publication Date:
- 2022-07
- Subjects:
- pancreas -- MRI -- CT -- volume -- perfusion -- artificial intelligence -- 3D - three-dimensional -- ACL - Artificial Intelligence Core Lab -- AI - artificial intelligence -- AP - acute pancreatitis -- CBD - common bile duct -- CIAL - Core Image Analysis Lab -- CT - computed tomography -- DCE MRI - dynamic contrast-enhanced MRI -- DM - diabetes mellitus -- DWI - diffusion-weighted imaging -- eGFR - estimated glomerular filtration rate -- EPD - exocrine pancreas dysfunction -- IVIM - intravoxel incoherent motion -- DL - deep learning -- DREAM - Diabetes RElated to Acute pancreatitis and its Mechanisms -- IMMINENT - Imaging Morphology of Pancreas in Diabetic Patients Following Acute Pancreatitis -- MRCP - MR cholangiopancreatography -- MRI - magnetic resonance imaging -- Pre-DM - prediabetes -- SegCaps - deep capsule–based segmentation networks -- SIR - signal intensity ratio -- SFTP - secure file transfer protocol -- T1DAPC - Type 1 Diabetes in Acute Pancreatitis Consortium -- T1D - type 1 diabetes mellitus -- T2D - type 2 diabetes mellitus
Pancreas -- Diseases -- Periodicals
Pancreas -- Periodicals
Neuroendocrine tumors -- Periodicals
616.37005 - Journal URLs:
- http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00006676-000000000-00000 ↗
http://www.pancreasjournal.com ↗
http://journals.lww.com/pancreasjournal/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/MPA.0000000000002080 ↗
- Languages:
- English
- ISSNs:
- 0885-3177
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6357.351500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24022.xml